1. Home
  2. TROO vs AVXL Comparison

TROO vs AVXL Comparison

Compare TROO & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

HOLD

Current Price

$2.28

Market Cap

480.1M

Sector

Technology

ML Signal

HOLD

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$2.99

Market Cap

430.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROO
AVXL
Founded
2005
2004
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
480.1M
430.9M
IPO Year
2008
2013

Fundamental Metrics

Financial Performance
Metric
TROO
AVXL
Price
$2.28
$2.99
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
153.7K
1.8M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$2.61
52 Week High
$5.28
$13.99

Technical Indicators

Market Signals
Indicator
TROO
AVXL
Relative Strength Index (RSI) 38.37 32.46
Support Level $0.74 $2.82
Resistance Level $2.74 $4.98
Average True Range (ATR) 0.29 0.27
MACD -0.02 -0.13
Stochastic Oscillator 46.84 17.08

Price Performance

Historical Comparison
TROO
AVXL

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: